Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

April 23, 2016 updated by: Sarah Lessard, Mayo Clinic
Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Wisconsin
      • La Crosse, Wisconsin, United States, 54601
        • Mayo Clinic Health System - Franciscan Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of heart failure, discharged from any medical service

Exclusion Criteria:

  • Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention

Discharge medication services included:

  • Discharge medication reconciliation
  • Identification of medication discrepancies and resolution
  • Medication counseling using health coaching techniques with short term goal setting and follow up phone call
Other: Pharmacist discharge medication services
Included in arm descriptions
No Intervention: Comparator
Current standard of care provided by nursing staff.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients readmitted to the hospital within 30 days of primary heart failure admission
Time Frame: 30 Days
Fisher's T-test
30 Days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients who visit the emergency department within 30 days of primary heart failure admission
Time Frame: 30 Days
Fisher's T-test
30 Days
Number of medication discrepancies identified and the number of medication discrepancies resolved by the pharmacist at discharge.
Time Frame: 30 Days
Fisher's T-test
30 Days
Number of short term goals set by patient's at discharge and the number of short term goals met by patient's at the 7-10 follow up phone call.
Time Frame: 30 days
Number of short term goals set will be compared to the number of goals patients achieved, comparison will be calculated by percentage
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mayo Clinic

Investigators

  • Principal Investigator: Sarah R Lessard, Pharm.D., Mayo Clinic Health System - Franciscan Healthcare

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

April 14, 2016

First Submitted That Met QC Criteria

April 23, 2016

First Posted (Estimate)

April 27, 2016

Study Record Updates

Last Update Posted (Estimate)

April 27, 2016

Last Update Submitted That Met QC Criteria

April 23, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15-008286

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Pharmacist discharge medication services

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe